PIVKA-II as a Potential New Biomarker for Hepatocellular Carcinoma – A Pilot Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PIVKA-II as a Potential New Biomarker for Hepatocellular Carcinoma – A Pilot Study

Published:2018 Issue:6 Volume:32 Page:1551-1554
ISSN:0258-851X
Container-title:In Vivo
language:en
Short-container-title:In Vivo

Author:

SVOBODOVA SARKA,KARLIKOVA MARIE,TOPOLCAN ONDREJ,PECEN LADISLAV,PESTOVA MARTINA,KOTT OTTO,TRESKA VLADISLAV,SLOUKA DAVID,KUCERA RADEK

Publisher

Anticancer Research USA Inc.

Subject

Pharmacology,General Biochemistry, Genetics and Molecular Biology,Cancer Research

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score;Hepatobiliary & Pancreatic Diseases International;2023-12

2. Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients;Heliyon;2023-11

3. Predictive value of PIVKA-II and AFP for the non-objective response of HBV-associated hepatocellular carcinoma after transarterial chemoembolization: a prospective study;European Journal of Gastroenterology & Hepatology;2023-10-25

4. Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2023-09

5. Clinical value of serum AFP and PIVKA‐II for diagnosis, treatment and prognosis of hepatocellular carcinoma;Journal of Clinical Laboratory Analysis;2022-12-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP